BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38645464)

  • 1. Regulating Tumor-Associated Macrophage Polarization by Cyclodextrin-Modified PLGA Nanoparticles Loaded with R848 for Treating Colon Cancer.
    Yuan H; Gui H; Chen S; Zhu L; Wang C; Jing Q; Lv H; Wan Q; Wang S; Zhou S; Ren X; Nie Y; Li L
    Int J Nanomedicine; 2024; 19():3589-3605. PubMed ID: 38645464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles.
    Zheng K; Huang Z; Huang J; Liu X; Ban J; Huang X; Luo H; Chen Z; Xie Q; Chen Y; Lu Z
    Drug Des Devel Ther; 2021; 15():2605-2618. PubMed ID: 34168432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-Functional PLGA Nanoparticles Co-Loaded with Indocyanine Green and Resiquimod for Prostate Cancer Treatment.
    Lin W; Li C; Xu N; Watanabe M; Xue R; Xu A; Araki M; Sun R; Liu C; Nasu Y; Huang P
    Int J Nanomedicine; 2021; 16():2775-2787. PubMed ID: 33880023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of 2-HP-β-cyclodextrin-PLGA nanoparticle complexes for potential use as ocular drug delivery vehicles.
    Li F; Wen Y; Zhang Y; Zheng K; Ban J; Xie Q; Wen Y; Liu Q; Chen F; Mo Z; Liu L; Chen Y; Lu Z
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4097-4108. PubMed ID: 31663388
    [No Abstract]   [Full Text] [Related]  

  • 5. PLGA Nanoparticle Platform for Trans-Ocular Barrier to Enhance Drug Delivery: A Comparative Study Based on the Application of Oligosaccharides in the Outer Membrane of Carriers.
    Jiang G; Jia H; Qiu J; Mo Z; Wen Y; Zhang Y; Wen Y; Xie Q; Ban J; Lu Z; Chen Y; Wu H; Ni Q; Chen F; Lu J; Wang Z; Li H; Chen J
    Int J Nanomedicine; 2020; 15():9373-9387. PubMed ID: 33262593
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Zhang L; Yang S; Wong LR; Xie H; Ho PC
    Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
    Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
    Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotin and arginine modified hydroxypropyl-β-cyclodextrin nanoparticles as novel drug delivery systems for paclitaxel.
    Yan C; Liang N; Li Q; Yan P; Sun S
    Carbohydr Polym; 2019 Jul; 216():129-139. PubMed ID: 31047049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity.
    Yin P; Wang Y; Qiu Y; Hou L; Liu X; Qin J; Duan Y; Liu P; Qiu M; Li Q
    Int J Nanomedicine; 2012; 7():3961-9. PubMed ID: 22888239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of resiquimod-loaded modified PLA-based nanoparticles for cancer immunotherapy: A kinetic study.
    Thauvin C; Widmer J; Mottas I; Hocevar S; Allémann E; Bourquin C; Delie F
    Eur J Pharm Biopharm; 2019 Jun; 139():253-261. PubMed ID: 30981947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy.
    Figueiredo P; Lepland A; Scodeller P; Fontana F; Torrieri G; Tiboni M; Shahbazi MA; Casettari L; Kostiainen MA; Hirvonen J; Teesalu T; Santos HA
    Acta Biomater; 2021 Oct; 133():231-243. PubMed ID: 33011297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
    Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
    BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoformulation of Paclitaxel: Exploring the Cyclodextrin / PLGA Nano Delivery Carrier to Slow Down Paclitaxel Release, Enhance Accumulation
    Ma P; Huang J; Liu J; Zhu Y; Chen J; Chen J; Lei L; Guan Z; Ban J; Lu Z
    J Cancer; 2023; 14(5):759-769. PubMed ID: 37056390
    [No Abstract]   [Full Text] [Related]  

  • 14. Sonication tailored enhance cytotoxicity of naringenin nanoparticle in pancreatic cancer: design, optimization, and
    Akhter MH; Kumar S; Nomani S
    Drug Dev Ind Pharm; 2020 Apr; 46(4):659-672. PubMed ID: 32208984
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary M1 macrophages as multifunctional carrier combined with PLGA nanoparticle delivering anticancer drug for efficient glioma therapy.
    Pang L; Zhu Y; Qin J; Zhao W; Wang J
    Drug Deliv; 2018 Nov; 25(1):1922-1931. PubMed ID: 30465444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Antitumor Efficacy of Curcumin-Loaded PLGA Nanoparticles Coated with Unique Fungal Hydrophobin.
    Sun L; Xu H; Xu JH; Wang SN; Wang JW; Zhang HF; Jia WR; Li LS
    AAPS PharmSciTech; 2020 Jun; 21(5):171. PubMed ID: 32529560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug.
    Li N; Wang N; Wu T; Qiu C; Wang X; Jiang S; Zhang Z; Liu T; Wei C; Wang T
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
    Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA
    Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-weight polyethylenimine cross-linked 2-hydroxypopyl-β-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA.
    Li JM; Wang YY; Zhang W; Su H; Ji LN; Mao ZW
    Int J Nanomedicine; 2013; 8():2101-17. PubMed ID: 23766646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinatorial delivery of antigen and TLR agonists via PLGA nanoparticles modulates Leishmania major-infected-macrophages activation.
    Katebi A; Varshochian R; Riazi-Rad F; Ganjalikhani-Hakemi M; Ajdary S
    Biomed Pharmacother; 2021 May; 137():111276. PubMed ID: 33485119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.